Takeda Pharmaceutical Co. Ltd. is to transfer the ownership of selected real estate assets in Japan - including its Osaka headquarters - to an undisclosed buyer to raise around JPY38bn ($347m) before tax ahead of the end of its current fiscal year on March 31.
Real Estate Sale, Including Osaka HQ, To Raise $347m For Takeda
As part of efforts to raise cash to pay for its acquisition of Shire, Takeda will sell off selected real estate holdings in Japan, including its Osaka HQ, to a mystery buyer.
